Miniature multi-channel SPR instrument for methotrexate monitoring in clinical samples.

[1]  J. Pelletier,et al.  Influence of the Debye length on the interaction of a small molecule-modified Au nanoparticle with a surface-bound bioreceptor. , 2014, Chemical communications.

[2]  Sandy Shuo Zhao,et al.  Imidazolium-based ionic liquid surfaces for biosensing. , 2013, Analytical chemistry.

[3]  J. Pelletier,et al.  Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor. , 2012, The Analyst.

[4]  Jean-Francois Masson,et al.  Nanostructured substrates for portable and miniature SPR biosensors , 2012, Analytical and Bioanalytical Chemistry.

[5]  Sandy Shuo Zhao,et al.  Modified peptide monolayer binding His-tagged biomolecules for small ligand screening with SPR biosensors. , 2011, The Analyst.

[6]  G. Sauvageau,et al.  Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells , 2011, Journal of molecular recognition : JMR.

[7]  Q. Cheng,et al.  New trends in instrumental design for surface plasmon resonance-based biosensors. , 2011, Biosensors & bioelectronics.

[8]  Sanjib Bhattacharyya,et al.  Inorganic Nanoparticles in Cancer Therapy , 2011, Pharmaceutical Research.

[9]  Marek Piliarik,et al.  Real-time monitoring of biomolecular interactions in blood plasma using a surface plasmon resonance biosensor , 2010, Analytical and bioanalytical chemistry.

[10]  Joelle N Pelletier,et al.  Multiple Conformers in Active Site of Human Dihydrofolate Reductase F31R/Q35E Double Mutant Suggest Structural Basis for Methotrexate Resistance* , 2009, The Journal of Biological Chemistry.

[11]  E. Fossati,et al.  2-Tier Bacterial and In Vitro Selection of Active and Methotrexate-Resistant Variants of Human Dihydrofolate Reductase , 2008, Journal of biomolecular screening.

[12]  A. Dasgupta.  Handbook of drug monitoring methods; therapeutics and drugs of abuse. , 2008 .

[13]  S. Soldin,et al.  An Improved Application for the Enzyme Multipled Immunoassay Technique for Caffeine, Amikacin, and Methotrexate Assays on the Dade-Behring Dimension RxL Max Clinical Chemistry System , 2007, Therapeutic drug monitoring.

[14]  Chao-Liang Wu,et al.  Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. , 2007, Molecular pharmaceutics.

[15]  G. Marchesini,et al.  Spreeta-based biosensor assays for endocrine disruptors. , 2007, Biosensors & bioelectronics.

[16]  Peter Kauffman,et al.  Portable 24-analyte surface plasmon resonance instruments for rapid, versatile biodetection. , 2007, Biosensors & bioelectronics.

[17]  J. Walling.  From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates , 2006, Investigational new drugs.

[18]  J. Lukas,et al.  Population Pharmacokinetics of High-Dose Methotrexate in Children with Acute Lymphoblastic Leukaemia , 2006, Clinical pharmacokinetics.

[19]  B. Lacarelle,et al.  Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma , 2004, Cancer Chemotherapy and Pharmacology.

[20]  J. Homola.  Present and future of surface plasmon resonance biosensors , 2003, Analytical and bioanalytical chemistry.

[21]  Jose Melendez,et al.  Detection of Staphylococcus aureus enterotoxin B at femtomolar levels with a miniature integrated two-channel surface plasmon resonance (SPR) sensor. , 2002, Biosensors & bioelectronics.

[22]  J. Seymour,et al.  Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  J. Henion,et al.  Liquid-liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma. , 1999, Analytical chemistry.

[24]  S. Eksborg,et al.  Evaluation of clinical assays for measuring high-dose methotrexate in plasma. , 1996, Clinical chemistry.

[25]  U. Bode,et al.  Methotrexate pharmacokinetics and prognosis in osteosarcoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  R. Schilsky,et al.  High-dose methotrexate: a critical reappraisal. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.